@FierceBiotech: RNAi, smuggled in a virus, weakens tumors before final radiation blow. More | Follow @FierceBiotech
@JohnCFierce: Note to pessimists: Maybe the sky isn't falling. Thoughts on the VC apocalypse. Piece | Follow @JohnCFierce
@RyanMFierce: Versant Ventures has named Roche vet Guido Magni a venture partner to aid Euro life sciences practice. Release | Follow @RyanMFierce
@FierceMedDev: White House OKs medical device act. News | Follow @FierceMedDev
> Staffing company Kforce is selling its clinical research business to CRO InVentiv Health for $50 million in cash and will focus instead on its core business, Reuters reports. Story
> Illumina ($ILMN) is urging stockholders at its April 18 annual meeting to reject Roche's ($RHHBY) unsolicited offer for the molecular diagnostics company. Release
> The FDA is voicing safety concerns over Talon Therapeutics' Mariqbo drug for associated peripheral neuropathy, because 15 patients have died during clinical trials, biotech analyst Adam Feuerstein Tweeted. Story
> NicOx SA stock jumped 11% last week, reaching the biggest weekly gain ever in Paris trading, Bloomberg reports, based on optimism over mid-stage clinical trial results for a glaucoma drug licensed to Bausch & Lomb. Story
> Canadian biotech QLT gained U.S. orphan drug status for Visudyne, which it is testing to treat chronic or recurrent central serous chorioretinopathy. The drug is already approved to treat age-related macular degeneration. Story
> Provectus Pharmaceuticals says it generated top line Phase I data in the first randomized controlled trial for its psoriasis treatment. Release
Pharma News
@FiercePharma: Pharma opportunity: Figure out how to get women to adhere to scripts, and docs to prescribe to women on par with men. Article | Follow @FiercePharma
> Abbott execs take pay cuts, but White still nabs $24M. More
> Treatment gap: Women get fewer standard heart drugs. Story
> Roche exec expects 'limited' rebound for pharma. Article
IT News
> Stanford algorithm uncovers drug side effects. Story
> Biomatters taps Ammundsen as CEO. Item
> GSK strikes deal to listen in on social media chatter. Article
> Medidata lauded on Wall Street; CEO takes shot at rival Oracle. More
Medical Device News
> Kensey Nash, St. Jude wrap up Angio-Seal dispute. Article
> Akili envisions video game as therapeutic device. Item
> Covidien scoops up pulmonary devicemaker for $300M. News
> i2Eye jumps into visual testing world. Story
And Finally... Guido Magni is joining Versant Ventures as a venture partner with a focus on innovative startups. He previously managed EuroVentures, a Versant biotech incubator. Release